DeutschNewstral
Article
newatlas.com on 2019-12-09 04:57
The resurrection of a failed Alzheimer’s drug set to test FDA approval
Related news
Eli Lilly applies for FDA approval on Alzheimer’s drugArkansas Online
FDA calls for federal investigation into approval of Alzheimer’s drugNew York Post
Alzheimer’s drug approval by FDA ‘rife with irregularities,’ probe findsLA Times- First new Alzheimer’s drug in decades receives controversial FDA approvalnewatlas.com
House investigation faults FDA, Biogen for Alzheimer’s drug approvalpost-gazette.com
Biogen Submits Promising Alzheimer’s Drug Aducanumab to FDA for Approvalobserver.com- BSigns Point to FDA Approval for Biogen’s Alzheimer’s Drugbarrons.com
A “disgraceful decision:” Researchers blast FDA for approving Alzheimer’s drugArs Technica
FDA Commissioner Calls For Inspector General Probe Into Biogen Alzheimer’s Drug ApprovalForbes
FDA head calls for investigation into agency approval of Alzheimer’s drugAlaska Dispatch News- Three experts resign as FDA advisors over approval of Alzheimer’s drugArs Technica
- BAfter Lengthy Delay, Biogen Submits Troubled Alzheimer’s Drug for FDA Approvalbarrons.com
- FDA Alzheimer’s call slammed as “Worst drug approval in recent US history”newatlas.com
- Controversial FDA Approval Of Alzheimer’s Drug Aducanumab Sets Stage For Possible Medicare Coverage BattleForbes
- FDA declines to give accelerated approval to Lilly’s Alzheimer’s drug, firm saysAlaska Dispatch News
- Eli Lilly to seek FDA approval for Alzheimer’s drug that firm says slows cognitive declineAlaska Dispatch News
- Alzheimer’s drug that failed early tests now dubbed effective, heads to FDAArs Technica
- FFDA approves Biogen Alzheimer’s drugft.com
First investigational drug to treat Alzheimer’s disease sent to FDA for approvalFOX 8 News Cleveland